Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings
Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事候选人声明与承诺（叶建亮） | 2025-12-15 | Chinese | |
| 关于参加独立董事培训并取得独立董事资格证书的承诺函（叶建亮） | 2025-12-15 | Chinese | |
| 独立董事提名人声明与承诺（叶建亮） | 2025-12-15 | Chinese | |
| 第四届董事会第二十九次会议决议公告 | 2025-12-15 | Chinese | |
| 贝达药业股份有限公司对外投资管理制度（2025年12月） | 2025-12-15 | Chinese | |
| 贝达药业股份有限公司董事会议事规则（草案）（2025年12月） | 2025-12-15 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37811656 | 独立董事候选人声明与承诺（叶建亮） | 2025-12-15 | Chinese | ||
| 37811653 | 关于参加独立董事培训并取得独立董事资格证书的承诺函（叶建亮） | 2025-12-15 | Chinese | ||
| 37811639 | 独立董事提名人声明与承诺（叶建亮） | 2025-12-15 | Chinese | ||
| 37811625 | 第四届董事会第二十九次会议决议公告 | 2025-12-15 | Chinese | ||
| 37811611 | 贝达药业股份有限公司对外投资管理制度（2025年12月） | 2025-12-15 | Chinese | ||
| 37811606 | 贝达药业股份有限公司董事会议事规则（草案）（2025年12月） | 2025-12-15 | Chinese | ||
| 37811603 | 关于修订《公司章程》并办理工商变更登记事项及修订公司部分内部治理制度的公告 | 2025-12-15 | Chinese | ||
| 37811602 | 关于董事会换届选举的公告 | 2025-12-15 | Chinese | ||
| 37811583 | 中信证券股份有限公司关于贝达药业股份有限公司使用部分闲置募集资金暂时补充流动资金的核查意见 | 2025-12-15 | Chinese | ||
| 37811566 | 关于召开2025年第二次临时股东大会的公告 | 2025-12-15 | Chinese | ||
| 37811552 | 贝达药业股份有限公司股东会议事规则（2025年12月） | 2025-12-15 | Chinese | ||
| 37811547 | 贝达药业股份有限公司募集资金管理制度（2025年12月） | 2025-12-15 | Chinese | ||
| 37811546 | 贝达药业股份有限公司对外担保制度（2025年12月） | 2025-12-15 | Chinese | ||
| 37811543 | 贝达药业股份有限公司关联交易决策制度（2025年12月） | 2025-12-15 | Chinese | ||
| 37811538 | 贝达药业股份有限公司董事会议事规则（2025年12月） | 2025-12-15 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Betta Pharmaceuticals Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55541/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55541 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55541 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55541 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55541}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Betta Pharmaceuticals Co.,Ltd (id: 55541)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.